These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1799184)

  • 1. Soluble interleukin-2 receptors in chronic renal failure.
    Hory B; Racadot E; Saint-Hillier Y; Peters A; Perol C
    Am J Nephrol; 1991; 11(4):276-80. PubMed ID: 1799184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble interleukin 2 receptor (sIL2R) in monitoring advanced lung cancer during chemotherapy.
    Brunetti G; Bossi A; Baiardi P; Jedrychowska I; Pozzi U; Bacchella L; Bernardo G
    Lung Cancer; 1999 Jan; 23(1):1-9. PubMed ID: 10100141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of mononuclear cell activation by hemodialysis.
    Donati D; Degiannis D; Combates N; Raskova J; Raska K
    ASAIO Trans; 1991; 37(3):M386-7. PubMed ID: 1751200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-lymphocyte activation in IgA nephropathy: serum-soluble interleukin 2 receptor level, interleukin 2 production, and interleukin 2 receptor expression by cultured lymphocytes.
    Lai KN; Leung JC; Lai FM; Tam JS
    J Clin Immunol; 1989 Nov; 9(6):485-92. PubMed ID: 2630571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.
    Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J
    Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients.
    Beaurain G; Naret C; Marcon L; Grateau G; Drueke T; Urena P; Nelson DL; Bach JF; Chatenoud L
    Kidney Int; 1989 Oct; 36(4):636-44. PubMed ID: 2681933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naïve and central memory T-cell lymphopenia in end-stage renal disease.
    Yoon JW; Gollapudi S; Pahl MV; Vaziri ND
    Kidney Int; 2006 Jul; 70(2):371-6. PubMed ID: 16738532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy.
    Costa E; Lima M; Alves JM; Rocha S; Rocha-Pereira P; Castro E; Miranda V; do SF; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
    J Clin Immunol; 2008 May; 28(3):268-75. PubMed ID: 18205031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc-mediated lymphocyte energy charge modification in dialysis patients.
    Bonomini M; Palmieri PF; Evangelista M; Manfrini V; Albertazzi A
    ASAIO Trans; 1991; 37(3):M387-9. PubMed ID: 1751201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year immunological evaluation of chronic hemodialysis in end-stage renal disease patients.
    Meier P; von Fliedner V; Markert M; van Melle G; Deppisch R; Wauters JP
    Blood Purif; 2000; 18(2):128-37. PubMed ID: 10838472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic T-lymphocyte activation in chronic renal failure: a study of hemodialysis, CAPD and pre-dialysis patients.
    Caruana RJ; Leffell MS; Lobel SA; Campbell HT; Cheek PL
    Int J Artif Organs; 1992 Feb; 15(2):93-8. PubMed ID: 1555882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients.
    Chung BH; Kim KW; Sun IO; Choi SR; Park HS; Jeon EJ; Kim BM; Choi BS; Park CW; Kim YS; Cho ML; Yang CW
    Immunol Lett; 2012 Jan; 141(2):181-9. PubMed ID: 22004873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory effects of secondary hyperparathyroidism on circulating CD4+ and CD8+ T-lymphocytes in chronic renal failure patients.
    El Kelany MA; Maklad SS; El Fouhil DF; El Etreby EA; Saleh LH; El Sheikh NA
    Egypt J Immunol; 2009; 16(2):71-82. PubMed ID: 22059355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cells in patients undergoing chronic hemodialysis: mitogenic response, suppressor activity, and interleukin-2 production and receptor generation.
    Raskova J; Ghobrial I; Shea SM; Ebert EC; Eisinger RP; Raska K
    Diagn Immunol; 1986; 4(4):209-16. PubMed ID: 2944684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immunity in hemodialysis patients: a quantitative analysis of immune cell subsets by flow cytometry.
    Deenitchina SS; Ando T; Okuda S; Kinukawa N; Hirakata H; Nagashima A; Fujishima M
    Am J Nephrol; 1995; 15(1):57-65. PubMed ID: 7872366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients on chronic hemodialysis have no intrinsic lymphocyte defect upon stimulation with interleukin-2, interleukin-15 or tumor necrosis factor-alpha.
    van Riemsdijk IC; Baan CC; Loonen EH; Zietse R; Weimar W
    Blood Purif; 2003; 21(2):158-62. PubMed ID: 12601258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subpopulations of t and B lymphocytes, rosette tests, levels of immunoglobulins in peripheral blood and NBT test in the initial period of hemodialysis conducted with cuprophan or cellulose acetate dialysers in patients with chronic renal failure].
    Starzyk J; Sarnecka S; Bartelik S; Heltman H; Partyka M
    Wiad Lek; 1993 Nov; 46(21-22):817-23. PubMed ID: 7817571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune disturbances during major depression: upregulated expression of interleukin-2 receptors.
    Maes M; Bosmans E; Suy E; Vandervorst C; De Jonckheere C; Raus J
    Neuropsychobiology; 1990-1991; 24(3):115-20. PubMed ID: 2135065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble serum interleukin 2 receptors in patients with asthma and allergic bronchopulmonary aspergillosis.
    Brown JE; Greenberger PA; Yarnold PR
    Ann Allergy Asthma Immunol; 1995 Jun; 74(6):484-8. PubMed ID: 7788514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella-zoster virus immune status in CAPD and chronic hemodialysis patients.
    Smetana Z; Leventon-Kriss S; Broide A; Jedwab M; Smetana SS
    Am J Nephrol; 1991; 11(3):229-36. PubMed ID: 1660222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.